文献速递生殖医学

不孕症随机对照试验中早期妊娠终点与活产的治疗效应一致性及统计学显著性:系统Meta流行病学研究

Consistency in treatment effects and statistical significance between early-stage pregnancy endpoints and live birth in randomized controlled trials of infertility: a systematic meta-epidemiological study.
PubMed 文献 · Fertil Steril · 2025-08-26

该系统Meta流行病学研究检索2012年1月1日至2023年8月30日不孕症随机对照试验,纳入1281项同时报告活产和至少一种早期妊娠终点的试验。生化妊娠与活产治疗效应Spearman rho为0.78,临床妊娠为0.87,持续妊娠为0.96;早期妊娠终点与活产的统计学显著性在超过88%的试验中一致。作者认为当活产数据有限或不可及时,临床或持续妊娠数据可用于评估治疗有效性,但需考虑干预相关妊娠丢失风险。

要点

  • 持续妊娠与活产的治疗效应相关性最高(rho=0.96),临床妊娠次之(rho=0.87),生化妊娠最低(rho=0.78)。
  • 早期妊娠终点与活产的统计学显著性在超过88%的试验中一致。
  • 临床或持续妊娠与活产的相关性在不孕症治疗亚组中保持稳健,包括医学辅助生殖的卵巢刺激。

核心结论

  • 临床或持续妊娠与活产之间观察到强相关性,支持在活产数据有限或不可及时使用临床或持续妊娠数据评估治疗有效性。
  • 评估时必须考虑干预相关妊娠丢失的风险。

研究设计与样本

  • 系统Meta流行病学研究,检索EMBASE、MEDLINE和CENTRAL数据库,时间范围为2012年1月1日至2023年8月30日。
  • 纳入涉及不孕女性的随机对照试验,要求报告活产和至少一种早期妊娠终点(生化、临床或持续妊娠)的列联表。
  • 共纳入1281项不孕症随机对照试验。
  • 计算早期妊娠终点与活产之间治疗效应的Spearman rho,并使用卡方检验比较统计学显著性。

主要发现

  • 生化妊娠与活产之间治疗效应的Spearman rho为0.78(95%CI:0.69-0.86,P<.001;169项RCT)。
  • 临床妊娠与活产之间治疗效应的Spearman rho为0.87(95%CI:0.83-0.90,P<.01;429项RCT)。
  • 持续妊娠与活产之间治疗效应的Spearman rho为0.96(95%CI:0.92-0.98,P<.01;138项RCT)。
  • 早期妊娠终点与活产之间的统计学显著性在超过88%的试验中一致。
  • 临床或持续妊娠与活产的治疗效应相关性在不孕症治疗亚组中保持稳健,包括医学辅助生殖的卵巢刺激。

临床怎么用

  • 原文结论认为,当活产数据有限或不可及时,临床或持续妊娠数据可用于评估治疗有效性。
  • 原文结论同时指出,评估时必须考虑干预相关妊娠丢失的风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Live births are the "gold standard" for assessing infertility treatments but are less frequently reported than clinical pregnancy. Identifying approaches to interpret randomized controlled trials (RCTs) without live birth data is essential. OBJECTIVE: To evaluate the correlation between treatment effects and the consistency of statistical significance in conclusions drawn from live birth versus early-stage pregnancy endpoints (an umbrella term defined as biochemical, clinical, or ongoing pregnancy) in RCTs reporting both outcomes. DATA SOURCES: We systematically searched EMBASE, MEDLINE, and CENTRAL for RCTs in infertility from January 1, 2012 to August 30, 2023. STUDY SELECTION AND SYNTHESIS: Randomized controlled trials involving subfertile women reporting contingency tables for live birth and at least one early-stage pregnancy endpoint were eligible. Contingency tables on pregnancy or live births were manually extracted from the trial publications. We calculated Spearman's rho for treatment effects between early-stage pregnancy endpoints and live birth and compared their statistical significance using Chi-square tests. The above analyses were then conducted in prespecified subgroups. MAIN OUTCOMES: The correlation between treatment effects and the consistency of statistical significance in conclusions drawn from live birth versus early-stage pregnancy endpoints. RESULTS: Among 8,757 records, 1,281 infertility RCTs were eligible. The Spearman's rho for treatment effects was 0.78 (95% confidence interval [CI]: 0.69-0.86, P<.001; 169 RCTs) between biochemical pregnancy and live birth, 0.87 (95% CI: 0.83-0.90, P<.01; 429 RCTs) between clinical pregnancy and live birth, and 0.96 (95% CI: 0.92-0.98, P<.01; 138 RCTs) between ongoing pregnancy and live birth. Statistical significance between early-stage pregnancy endpoints and live birth was consistent in above 88% of trials. The correlation of treatment effects between clinical or ongoing pregnancy and live birth remained robust in subgroups of infertility treatments, including ovarian stimulation for medically assisted reproduction treatment. CONCLUSION AND RELEVANCE: A strong correlation was observed between clinical or ongoing pregnancy and live birth, supporting the rationale for using clinical or ongoing pregnancy data to assess treatment effectiveness when live birth data are limited or unavailable. However, the risk of intervention-related pregnancy loss must be considered during the assessment.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Feng Q, Li W, Crispin J, et al. Consistency in treatment effects and statistical significance between early-stage pregnancy endpoints and live birth in randomized controlled trials of infertility: a systematic meta-epidemiological study. Fertil Steril. 2025. PMID: 40876726. doi:10.1016/j.fertnstert.2025.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。